UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation

Leukemia, 2012-12, Vol.26 (12), p.2462-2468

2012

Volltextzugriff (PDF)

Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis

Bone marrow transplantation (Basingstoke), 2013-06, Vol.48 (6), p.819-824

2013

Volltextzugriff (PDF)

Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Annals of oncology, 2016-12, Vol.27 (12), p.2251-2257

2016

Volltextzugriff (PDF)

Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire

Leukemia, 2010-11, Vol.24 (11), p.1867-1874

2010

Volltextzugriff (PDF)

Incidence and risk factors of EBV reactivation after unrelated cord blood transplantation: a Eurocord and Societe Française de Greffe de Moelle-Therapie Cellulaire collaborative study

Bone marrow transplantation (Basingstoke), 2013-02, Vol.48 (2), p.253-256

2013

Volltextzugriff (PDF)

Chronic graft‐versus‐host disease and inhibition of interleukin‐17: proof of concept in humans

British journal of dermatology (1951), 2020-04, Vol.182 (4), p.1038-1041

2020

Volltextzugriff (PDF)

The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation

Leukemia, 2010-11, Vol.24 (11), p.1852-1858

2010

Volltextzugriff (PDF)

Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis

Bone marrow transplantation (Basingstoke), 2014-01, Vol.49 (1), p.24-29

2014

Volltextzugriff (PDF)

Allogeneic hematopoietic SCT for adults AML using i.v. BU in the conditioning regimen: outcomes and risk factors for the occurrence of hepatic sinusoidal obstructive syndrome

Bone marrow transplantation (Basingstoke), 2014-05, Vol.49 (5), p.628-633

2014

Volltextzugriff (PDF)

Complete remission of sclerodermatous cutaneous graft‐versus‐host disease after low‐dose interleukine‐2 treatment

Journal of the European Academy of Dermatology and Venereology, 2020-12, Vol.34 (12), p.e791-e793

2020

Volltextzugriff (PDF)

Fecal calprotectin and α1-antitrypsin dynamics in gastrointestinal GvHD

Bone marrow transplantation (Basingstoke), 2015-08, Vol.50 (8), p.1105-1109

2015

Volltextzugriff (PDF)

Impact of comorbidity indexes on non-relapse mortality

Leukemia, 2008-11, Vol.22 (11), p.2062-2069

2008

Volltextzugriff (PDF)

Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice

Bone marrow transplantation (Basingstoke), 2014-02, Vol.49 (2), p.168-173

2014

Volltextzugriff (PDF)

Correction to: Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality

Leukemia, 2021-03, Vol.35 (3), p.934-934

2021

Volltextzugriff (PDF)

The NIH consensus criteria for chronic graft-versus-host disease: far more than just another classification

Leukemia, 2009-01, Vol.23 (1), p.1-2

Socie, G

2009

Volltextzugriff (PDF)

Recent improvement in outcome of unrelated donor transplantation for aplastic anemia

Bone marrow transplantation (Basingstoke), 2008-01, Vol.41 (1), p.45-50

2008

Volltextzugriff (PDF)

Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality

Leukemia, 2021-01, Vol.35 (1), p.225-228

2021

Volltextzugriff (PDF)

Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and Eurocord

Bone marrow transplantation (Basingstoke), 2017-10, Vol.52 (10), p.1428-1435

2017

Volltextzugriff (PDF)

Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties

Bone marrow transplantation (Basingstoke), 2007-06, Vol.39 (11), p.667-675

2007

Volltextzugriff (PDF)

Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2007-05, Vol.39 (9), p.547-553

2007

Volltextzugriff (PDF)

New mutations of MPL in primitive myelofibrosis : only the MPL W515 mutations promote a G1/S-phase transition

Leukemia, 2008-08, Vol.22 (8), p.1557-1566

2008

Volltextzugriff (PDF)

In situ chimerism after double cord blood transplantation

Bone marrow transplantation (Basingstoke), 2013-11, Vol.48 (12), p.1582-1582

2013

Volltextzugriff (PDF)

KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia

Leukemia, 2009-03, Vol.23 (3), p.492-500

2009

Volltextzugriff (PDF)

S235: A TWO‐PART, SINGLE‐ AND TWO‐ARM RANDOMIZED, OPEN‐LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THE S1P RECEPTOR MODULATOR KRP203 IN SUBJECTS WITH HEMATOLOGICAL MALIGNANCIES

HemaSphere, 2022-06, Vol.6, p.136-137

2022

Volltextzugriff (PDF)

1 – 25 von 718

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(643)
Mit Volltextzugriff
(580)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(433)
Humans
(428)
Life Sciences & Biomedicine
(427)
Hematology
(312)
Male
(295)
Female
(290)
Adult
(276)
Biological And Medical Sciences
(241)
Medical Sciences
(236)
Middle Aged
(216)
Transplantation
(190)
Adolescent
(189)
Immunology
(153)
Oncology
(152)
Child
(151)
Retrospective Studies
(139)
Stem Cell Transplantation
(127)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(126)
Transplantation, Homologous
(126)
Transfusions. Complications. Transfusion Reactions. Cell And Gene Therapy
(125)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation

Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis

Myeloablative versus reduced intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma in recent years: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire

Incidence and risk factors of EBV reactivation after unrelated cord blood transplantation: a Eurocord and Societe Française de Greffe de Moelle-Therapie Cellulaire collaborative study

Chronic graft‐versus‐host disease and inhibition of interleukin‐17: proof of concept in humans

The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation

Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis

Allogeneic hematopoietic SCT for adults AML using i.v. BU in the conditioning regimen: outcomes and risk factors for the occurrence of hepatic sinusoidal obstructive syndrome

Complete remission of sclerodermatous cutaneous graft‐versus‐host disease after low‐dose interleukine‐2 treatment

Fecal calprotectin and α1-antitrypsin dynamics in gastrointestinal GvHD

Impact of comorbidity indexes on non-relapse mortality

Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice

Correction to: Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality

The NIH consensus criteria for chronic graft-versus-host disease: far more than just another classification

Recent improvement in outcome of unrelated donor transplantation for aplastic anemia

Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation

New mutations of MPL in primitive myelofibrosis : only the MPL W515 mutations promote a G1/S-phase transition

In situ chimerism after double cord blood transplantation

KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia

S235: A TWO‐PART, SINGLE‐ AND TWO‐ARM RANDOMIZED, OPEN‐LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THE S1P RECEPTOR MODULATOR KRP203 IN SUBJECTS WITH HEMATOLOGICAL MALIGNANCIES

Suchergebnisse filtern